학술논문
Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis
Document Type
Academic Journal
Author
Source
Clinical and Translational Medicine. September 23, 2020, Vol. 10 Issue 5
Subject
Language
English
Abstract
Dear Editor, Tofacitinib is a potent and orally active inhibitor of the JAK family (with high selectivity to JAK‐1 and JAK‐3), which suppresses inflammatory signaling of γc‐chain cytokines that have [...]